nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—CHRM1—epilepsy syndrome	0.143	0.362	CbGaD
Triflupromazine—CHRM2—epilepsy syndrome	0.117	0.295	CbGaD
Triflupromazine—BCHE—epilepsy syndrome	0.0976	0.246	CbGaD
Triflupromazine—ABCB1—epilepsy syndrome	0.0382	0.0965	CbGaD
Triflupromazine—ABCB1—Levetiracetam—epilepsy syndrome	0.0265	0.208	CbGbCtD
Triflupromazine—Desipramine—Carbamazepine—epilepsy syndrome	0.0239	0.0634	CrCrCtD
Triflupromazine—Desipramine—Oxcarbazepine—epilepsy syndrome	0.022	0.0584	CrCrCtD
Triflupromazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0216	0.0574	CrCrCtD
Triflupromazine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0202	0.0536	CrCrCtD
Triflupromazine—Imipramine—Carbamazepine—epilepsy syndrome	0.0194	0.0514	CrCrCtD
Triflupromazine—Methdilazine—Carbamazepine—epilepsy syndrome	0.019	0.0504	CrCrCtD
Triflupromazine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0186	0.0494	CrCrCtD
Triflupromazine—ABCB1—Clobazam—epilepsy syndrome	0.0184	0.144	CbGbCtD
Triflupromazine—Clomipramine—Clobazam—epilepsy syndrome	0.0182	0.0484	CrCrCtD
Triflupromazine—Promethazine—Carbamazepine—epilepsy syndrome	0.0179	0.0475	CrCrCtD
Triflupromazine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0178	0.0473	CrCrCtD
Triflupromazine—Chlorprothixene—Midazolam—epilepsy syndrome	0.0178	0.0473	CrCrCtD
Triflupromazine—ABCB1—Lamotrigine—epilepsy syndrome	0.0177	0.139	CbGbCtD
Triflupromazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0176	0.0467	CrCrCtD
Triflupromazine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0175	0.0464	CrCrCtD
Triflupromazine—Clomipramine—Diazepam—epilepsy syndrome	0.017	0.045	CrCrCtD
Triflupromazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0165	0.0438	CrCrCtD
Triflupromazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0162	0.043	CrCrCtD
Triflupromazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.0161	0.0428	CrCrCtD
Triflupromazine—Chlorprothixene—Diazepam—epilepsy syndrome	0.0159	0.0422	CrCrCtD
Triflupromazine—ABCB1—Carbamazepine—epilepsy syndrome	0.0152	0.12	CbGbCtD
Triflupromazine—Promazine—Carbamazepine—epilepsy syndrome	0.0152	0.0402	CrCrCtD
Triflupromazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0145	0.0384	CrCrCtD
Triflupromazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.014	0.037	CrCrCtD
Triflupromazine—ABCB1—Phenytoin—epilepsy syndrome	0.0137	0.107	CbGbCtD
Triflupromazine—ABCB1—Phenobarbital—epilepsy syndrome	0.0122	0.0957	CbGbCtD
Triflupromazine—ABCB1—Midazolam—epilepsy syndrome	0.012	0.0944	CbGbCtD
Triflupromazine—ABCB1—Diazepam—epilepsy syndrome	0.0115	0.0907	CbGbCtD
Triflupromazine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00286	0.109	CbGeAlD
Triflupromazine—DRD1—ganglion—epilepsy syndrome	0.00178	0.0681	CbGeAlD
Triflupromazine—DRD2—telencephalic ventricle—epilepsy syndrome	0.00169	0.0647	CbGeAlD
Triflupromazine—DRD2—ganglion—epilepsy syndrome	0.00105	0.0402	CbGeAlD
Triflupromazine—DRD2—hindbrain—epilepsy syndrome	0.000799	0.0305	CbGeAlD
Triflupromazine—DRD1—brainstem—epilepsy syndrome	0.000775	0.0296	CbGeAlD
Triflupromazine—DRD1—forebrain—epilepsy syndrome	0.000748	0.0286	CbGeAlD
Triflupromazine—DRD1—telencephalon—epilepsy syndrome	0.000688	0.0263	CbGeAlD
Triflupromazine—CHRM2—forebrain—epilepsy syndrome	0.000603	0.023	CbGeAlD
Triflupromazine—CHRM2—telencephalon—epilepsy syndrome	0.000554	0.0212	CbGeAlD
Triflupromazine—CHRM1—forebrain—epilepsy syndrome	0.000549	0.021	CbGeAlD
Triflupromazine—HTR2B—forebrain—epilepsy syndrome	0.000546	0.0209	CbGeAlD
Triflupromazine—CHRM1—telencephalon—epilepsy syndrome	0.000504	0.0193	CbGeAlD
Triflupromazine—HTR2B—telencephalon—epilepsy syndrome	0.000502	0.0192	CbGeAlD
Triflupromazine—DRD1—midbrain—epilepsy syndrome	0.000494	0.0189	CbGeAlD
Triflupromazine—DRD2—brainstem—epilepsy syndrome	0.000458	0.0175	CbGeAlD
Triflupromazine—DRD2—forebrain—epilepsy syndrome	0.000442	0.0169	CbGeAlD
Triflupromazine—DRD1—head—epilepsy syndrome	0.000428	0.0164	CbGeAlD
Triflupromazine—BCHE—brainstem—epilepsy syndrome	0.000415	0.0159	CbGeAlD
Triflupromazine—DRD2—telencephalon—epilepsy syndrome	0.000406	0.0155	CbGeAlD
Triflupromazine—DRD1—nervous system—epilepsy syndrome	0.000406	0.0155	CbGeAlD
Triflupromazine—BCHE—forebrain—epilepsy syndrome	0.000401	0.0153	CbGeAlD
Triflupromazine—DRD1—central nervous system—epilepsy syndrome	0.000391	0.0149	CbGeAlD
Triflupromazine—BCHE—telencephalon—epilepsy syndrome	0.000368	0.0141	CbGeAlD
Triflupromazine—CHRM2—head—epilepsy syndrome	0.000345	0.0132	CbGeAlD
Triflupromazine—CHRM2—nervous system—epilepsy syndrome	0.000327	0.0125	CbGeAlD
Triflupromazine—CHRM2—central nervous system—epilepsy syndrome	0.000315	0.012	CbGeAlD
Triflupromazine—CHRM1—head—epilepsy syndrome	0.000314	0.012	CbGeAlD
Triflupromazine—HTR2B—head—epilepsy syndrome	0.000312	0.0119	CbGeAlD
Triflupromazine—DRD1—brain—epilepsy syndrome	0.00031	0.0119	CbGeAlD
Triflupromazine—CHRM1—nervous system—epilepsy syndrome	0.000298	0.0114	CbGeAlD
Triflupromazine—HTR2B—nervous system—epilepsy syndrome	0.000296	0.0113	CbGeAlD
Triflupromazine—DRD2—midbrain—epilepsy syndrome	0.000292	0.0111	CbGeAlD
Triflupromazine—BCHE—medulla oblongata—epilepsy syndrome	0.00029	0.0111	CbGeAlD
Triflupromazine—CHRM1—central nervous system—epilepsy syndrome	0.000287	0.011	CbGeAlD
Triflupromazine—HTR2B—central nervous system—epilepsy syndrome	0.000285	0.0109	CbGeAlD
Triflupromazine—BCHE—midbrain—epilepsy syndrome	0.000265	0.0101	CbGeAlD
Triflupromazine—BCHE—spinal cord—epilepsy syndrome	0.000258	0.00986	CbGeAlD
Triflupromazine—DRD2—head—epilepsy syndrome	0.000253	0.00967	CbGeAlD
Triflupromazine—CHRM2—brain—epilepsy syndrome	0.00025	0.00956	CbGeAlD
Triflupromazine—DRD2—nervous system—epilepsy syndrome	0.00024	0.00917	CbGeAlD
Triflupromazine—DRD2—central nervous system—epilepsy syndrome	0.000231	0.00882	CbGeAlD
Triflupromazine—BCHE—head—epilepsy syndrome	0.000229	0.00877	CbGeAlD
Triflupromazine—CHRM1—brain—epilepsy syndrome	0.000228	0.0087	CbGeAlD
Triflupromazine—HTR2B—brain—epilepsy syndrome	0.000226	0.00865	CbGeAlD
Triflupromazine—DRD2—cerebellum—epilepsy syndrome	0.000226	0.00862	CbGeAlD
Triflupromazine—BCHE—nervous system—epilepsy syndrome	0.000218	0.00831	CbGeAlD
Triflupromazine—BCHE—central nervous system—epilepsy syndrome	0.000209	0.008	CbGeAlD
Triflupromazine—BCHE—cerebellum—epilepsy syndrome	0.000205	0.00782	CbGeAlD
Triflupromazine—ABCB1—forebrain—epilepsy syndrome	0.000191	0.0073	CbGeAlD
Triflupromazine—DRD2—brain—epilepsy syndrome	0.000183	0.00701	CbGeAlD
Triflupromazine—ABCB1—telencephalon—epilepsy syndrome	0.000176	0.00671	CbGeAlD
Triflupromazine—BCHE—brain—epilepsy syndrome	0.000166	0.00635	CbGeAlD
Triflupromazine—Imipramine—KCND2—epilepsy syndrome	0.000149	0.0406	CrCbGaD
Triflupromazine—ABCB1—medulla oblongata—epilepsy syndrome	0.000138	0.00527	CbGeAlD
Triflupromazine—ABCB1—midbrain—epilepsy syndrome	0.000126	0.00482	CbGeAlD
Triflupromazine—ABCB1—spinal cord—epilepsy syndrome	0.000123	0.0047	CbGeAlD
Triflupromazine—ABCB1—head—epilepsy syndrome	0.000109	0.00418	CbGeAlD
Triflupromazine—ABCB1—nervous system—epilepsy syndrome	0.000104	0.00396	CbGeAlD
Triflupromazine—ABCB1—central nervous system—epilepsy syndrome	9.98e-05	0.00381	CbGeAlD
Triflupromazine—ABCB1—cerebellum—epilepsy syndrome	9.76e-05	0.00373	CbGeAlD
Triflupromazine—Ethopropazine—CHRM1—epilepsy syndrome	9.74e-05	0.0265	CrCbGaD
Triflupromazine—Cyamemazine—CHRM2—epilepsy syndrome	9.38e-05	0.0255	CrCbGaD
Triflupromazine—Mequitazine—CHRM2—epilepsy syndrome	8.15e-05	0.0222	CrCbGaD
Triflupromazine—Propericiazine—ADRA2A—epilepsy syndrome	8.01e-05	0.0218	CrCbGaD
Triflupromazine—Ethopropazine—CHRM2—epilepsy syndrome	7.96e-05	0.0216	CrCbGaD
Triflupromazine—ABCB1—brain—epilepsy syndrome	7.92e-05	0.00303	CbGeAlD
Triflupromazine—Ethopropazine—BCHE—epilepsy syndrome	6.64e-05	0.0181	CrCbGaD
Triflupromazine—Propiomazine—CHRM3—epilepsy syndrome	6.33e-05	0.0172	CrCbGaD
Triflupromazine—Chlorprothixene—CHRM3—epilepsy syndrome	5.99e-05	0.0163	CrCbGaD
Triflupromazine—Propiomazine—CHRM1—epilepsy syndrome	5.9e-05	0.0161	CrCbGaD
Triflupromazine—Mesoridazine—CHRM2—epilepsy syndrome	5.72e-05	0.0156	CrCbGaD
Triflupromazine—Cinacalcet—CYP2D6—epilepsy syndrome	5.72e-05	0.0156	CrCbGaD
Triflupromazine—Chlorprothixene—CHRM1—epilepsy syndrome	5.59e-05	0.0152	CrCbGaD
Triflupromazine—Prochlorperazine—CHRM2—epilepsy syndrome	5.54e-05	0.0151	CrCbGaD
Triflupromazine—Methotrimeprazine—CHRM3—epilepsy syndrome	5.41e-05	0.0147	CrCbGaD
Triflupromazine—Promethazine—CHRM3—epilepsy syndrome	5.33e-05	0.0145	CrCbGaD
Triflupromazine—Methotrimeprazine—CHRM1—epilepsy syndrome	5.05e-05	0.0137	CrCbGaD
Triflupromazine—Promethazine—CHRM1—epilepsy syndrome	4.97e-05	0.0135	CrCbGaD
Triflupromazine—Desipramine—CHRM3—epilepsy syndrome	4.84e-05	0.0132	CrCbGaD
Triflupromazine—Propiomazine—CHRM2—epilepsy syndrome	4.82e-05	0.0131	CrCbGaD
Triflupromazine—Cyamemazine—HTR2A—epilepsy syndrome	4.7e-05	0.0128	CrCbGaD
Triflupromazine—Promazine—CHRM3—epilepsy syndrome	4.69e-05	0.0128	CrCbGaD
Triflupromazine—Chlorprothixene—CHRM2—epilepsy syndrome	4.56e-05	0.0124	CrCbGaD
Triflupromazine—Desipramine—CHRM1—epilepsy syndrome	4.52e-05	0.0123	CrCbGaD
Triflupromazine—Diltiazem—CYP2C19—epilepsy syndrome	4.51e-05	0.0123	CrCbGaD
Triflupromazine—Promazine—CHRM1—epilepsy syndrome	4.37e-05	0.0119	CrCbGaD
Triflupromazine—Thioridazine—CHRM2—epilepsy syndrome	4.32e-05	0.0117	CrCbGaD
Triflupromazine—Thioridazine—HTR7—epilepsy syndrome	4.3e-05	0.0117	CrCbGaD
Triflupromazine—Fluphenazine—ADRA2A—epilepsy syndrome	4.28e-05	0.0116	CrCbGaD
Triflupromazine—Chlorpromazine—CHRM3—epilepsy syndrome	4.13e-05	0.0112	CrCbGaD
Triflupromazine—Methotrimeprazine—CHRM2—epilepsy syndrome	4.12e-05	0.0112	CrCbGaD
Triflupromazine—Imipramine—CHRM3—epilepsy syndrome	4.11e-05	0.0112	CrCbGaD
Triflupromazine—Promethazine—CHRM2—epilepsy syndrome	4.06e-05	0.011	CrCbGaD
Triflupromazine—Trifluoperazine—CHRM2—epilepsy syndrome	4.01e-05	0.0109	CrCbGaD
Triflupromazine—Perphenazine—HTR7—epilepsy syndrome	3.94e-05	0.0107	CrCbGaD
Triflupromazine—Clomipramine—ADRA2A—epilepsy syndrome	3.91e-05	0.0106	CrCbGaD
Triflupromazine—Chlorpromazine—CHRM1—epilepsy syndrome	3.85e-05	0.0105	CrCbGaD
Triflupromazine—Imipramine—CHRM1—epilepsy syndrome	3.83e-05	0.0104	CrCbGaD
Triflupromazine—Mequitazine—CYP2D6—epilepsy syndrome	3.73e-05	0.0101	CrCbGaD
Triflupromazine—Desipramine—CHRM2—epilepsy syndrome	3.69e-05	0.01	CrCbGaD
Triflupromazine—Thioridazine—ADRA2A—epilepsy syndrome	3.68e-05	0.01	CrCbGaD
Triflupromazine—Pipotiazine—CYP2C19—epilepsy syndrome	3.58e-05	0.00973	CrCbGaD
Triflupromazine—Promazine—CHRM2—epilepsy syndrome	3.57e-05	0.00972	CrCbGaD
Triflupromazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	3.52e-05	0.00957	CrCbGaD
Triflupromazine—Perphenazine—ADRA2A—epilepsy syndrome	3.38e-05	0.0092	CrCbGaD
Triflupromazine—Diltiazem—CYP2D6—epilepsy syndrome	3.35e-05	0.0091	CrCbGaD
Triflupromazine—Chlorpromazine—CHRM2—epilepsy syndrome	3.14e-05	0.00855	CrCbGaD
Triflupromazine—Chlorpromazine—HTR7—epilepsy syndrome	3.13e-05	0.00851	CrCbGaD
Triflupromazine—Imipramine—CHRM2—epilepsy syndrome	3.13e-05	0.00851	CrCbGaD
Triflupromazine—Imipramine—HTR7—epilepsy syndrome	3.11e-05	0.00847	CrCbGaD
Triflupromazine—Promazine—ADRA2A—epilepsy syndrome	3.05e-05	0.00829	CrCbGaD
Triflupromazine—Acepromazine—HTR2A—epilepsy syndrome	3.02e-05	0.00821	CrCbGaD
Triflupromazine—Clomipramine—SLC6A4—epilepsy syndrome	2.98e-05	0.00812	CrCbGaD
Triflupromazine—Thioproperazine—HTR2A—epilepsy syndrome	2.95e-05	0.00802	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—epilepsy syndrome	2.9e-05	0.00789	CrCbGaD
Triflupromazine—Mesoridazine—HTR2A—epilepsy syndrome	2.86e-05	0.00779	CrCbGaD
Triflupromazine—Clomipramine—CYP2C19—epilepsy syndrome	2.83e-05	0.0077	CrCbGaD
Triflupromazine—Chlorpromazine—ADRA2A—epilepsy syndrome	2.68e-05	0.0073	CrCbGaD
Triflupromazine—Thioridazine—CYP2C19—epilepsy syndrome	2.66e-05	0.00725	CrCbGaD
Triflupromazine—Pipotiazine—CYP2D6—epilepsy syndrome	2.65e-05	0.00722	CrCbGaD
Triflupromazine—Chlorpromazine—BCHE—epilepsy syndrome	2.62e-05	0.00713	CrCbGaD
Triflupromazine—Mesoridazine—CYP2D6—epilepsy syndrome	2.62e-05	0.00712	CrCbGaD
Triflupromazine—Prochlorperazine—CYP2D6—epilepsy syndrome	2.54e-05	0.0069	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—epilepsy syndrome	2.51e-05	0.00682	CrCbGaD
Triflupromazine—Perphenazine—CYP2C19—epilepsy syndrome	2.45e-05	0.00665	CrCbGaD
Triflupromazine—Propiomazine—HTR2A—epilepsy syndrome	2.41e-05	0.00656	CrCbGaD
Triflupromazine—Desipramine—SLC6A4—epilepsy syndrome	2.4e-05	0.00653	CrCbGaD
Triflupromazine—Diltiazem—ABCB1—epilepsy syndrome	2.39e-05	0.0065	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—epilepsy syndrome	2.29e-05	0.00624	CrCbGaD
Triflupromazine—Fluphenazine—CYP2D6—epilepsy syndrome	2.29e-05	0.00624	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—epilepsy syndrome	2.28e-05	0.00621	CrCbGaD
Triflupromazine—Desipramine—CYP2C19—epilepsy syndrome	2.28e-05	0.00619	CrCbGaD
Triflupromazine—Promazine—CYP2C19—epilepsy syndrome	2.2e-05	0.006	CrCbGaD
Triflupromazine—Thioridazine—HTR2A—epilepsy syndrome	2.16e-05	0.00588	CrCbGaD
Triflupromazine—Clomipramine—CYP2D6—epilepsy syndrome	2.1e-05	0.00571	CrCbGaD
Triflupromazine—Acepromazine—ALB—epilepsy syndrome	2.06e-05	0.00562	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2A—epilepsy syndrome	2.06e-05	0.00561	CrCbGaD
Triflupromazine—Imipramine—SLC6A4—epilepsy syndrome	2.04e-05	0.00554	CrCbGaD
Triflupromazine—Promethazine—HTR2A—epilepsy syndrome	2.03e-05	0.00553	CrCbGaD
Triflupromazine—Thioproperazine—ALB—epilepsy syndrome	2.02e-05	0.00549	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—epilepsy syndrome	2e-05	0.00545	CrCbGaD
Triflupromazine—Pipotiazine—ALB—epilepsy syndrome	1.99e-05	0.0054	CrCbGaD
Triflupromazine—Perphenazine—HTR2A—epilepsy syndrome	1.98e-05	0.00539	CrCbGaD
Triflupromazine—Thioridazine—CYP2D6—epilepsy syndrome	1.98e-05	0.00537	CrCbGaD
Triflupromazine—Imipramine—CYP2C19—epilepsy syndrome	1.93e-05	0.00525	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	1.89e-05	0.00513	CrCbGaD
Triflupromazine—Promethazine—CYP2D6—epilepsy syndrome	1.86e-05	0.00505	CrCbGaD
Triflupromazine—Desipramine—HTR2A—epilepsy syndrome	1.85e-05	0.00502	CrCbGaD
Triflupromazine—Perphenazine—CYP2D6—epilepsy syndrome	1.81e-05	0.00493	CrCbGaD
Triflupromazine—Promazine—HTR2A—epilepsy syndrome	1.79e-05	0.00486	CrCbGaD
Triflupromazine—Desipramine—CYP2D6—epilepsy syndrome	1.69e-05	0.00459	CrCbGaD
Triflupromazine—Fluphenazine—ABCB1—epilepsy syndrome	1.64e-05	0.00445	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2A—epilepsy syndrome	1.57e-05	0.00428	CrCbGaD
Triflupromazine—Clomipramine—ALB—epilepsy syndrome	1.57e-05	0.00427	CrCbGaD
Triflupromazine—Imipramine—HTR2A—epilepsy syndrome	1.56e-05	0.00426	CrCbGaD
Triflupromazine—Clomipramine—ABCB1—epilepsy syndrome	1.5e-05	0.00407	CrCbGaD
Triflupromazine—Chlorprothixene—ABCB1—epilepsy syndrome	1.49e-05	0.00406	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2D6—epilepsy syndrome	1.44e-05	0.00391	CrCbGaD
Triflupromazine—Imipramine—CYP2D6—epilepsy syndrome	1.43e-05	0.00389	CrCbGaD
Triflupromazine—Promethazine—ABCB1—epilepsy syndrome	1.33e-05	0.00361	CrCbGaD
Triflupromazine—Trifluoperazine—ABCB1—epilepsy syndrome	1.31e-05	0.00356	CrCbGaD
Triflupromazine—Desipramine—ABCB1—epilepsy syndrome	1.2e-05	0.00328	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—epilepsy syndrome	1.08e-05	0.00293	CrCbGaD
Triflupromazine—Chlorpromazine—ABCB1—epilepsy syndrome	1.03e-05	0.00279	CrCbGaD
Triflupromazine—Imipramine—ABCB1—epilepsy syndrome	1.02e-05	0.00278	CrCbGaD
Triflupromazine—DRD1—Signaling Pathways—SOCS3—epilepsy syndrome	5e-06	7.16e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDC42—epilepsy syndrome	4.99e-06	7.14e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GPX1—epilepsy syndrome	4.98e-06	7.13e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.96e-06	7.1e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.96e-06	7.1e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	4.95e-06	7.08e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	4.95e-06	7.08e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	4.88e-06	6.97e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.86e-06	6.94e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	4.85e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	4.84e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	4.84e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AVP—epilepsy syndrome	4.83e-06	6.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	4.81e-06	6.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	4.81e-06	6.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SST—epilepsy syndrome	4.81e-06	6.89e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.79e-06	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	4.78e-06	6.84e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	4.78e-06	6.84e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	4.77e-06	6.83e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	4.77e-06	6.82e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	4.71e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	4.7e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	4.69e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	4.69e-06	6.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	4.67e-06	6.68e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	4.65e-06	6.65e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	4.65e-06	6.65e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	4.65e-06	6.65e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.61e-06	6.59e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	4.61e-06	6.59e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	4.59e-06	6.57e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HES1—epilepsy syndrome	4.57e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.55e-06	6.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.53e-06	6.48e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	4.53e-06	6.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	4.53e-06	6.47e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.53e-06	6.47e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	4.52e-06	6.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.51e-06	6.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.49e-06	6.42e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	4.48e-06	6.41e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FYN—epilepsy syndrome	4.44e-06	6.36e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	4.44e-06	6.35e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	4.44e-06	6.35e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.43e-06	6.34e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.43e-06	6.34e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—H2AFX—epilepsy syndrome	4.43e-06	6.33e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	4.43e-06	6.33e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.42e-06	6.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MEF2C—epilepsy syndrome	4.42e-06	6.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.41e-06	6.31e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.39e-06	6.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.37e-06	6.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.37e-06	6.25e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AGT—epilepsy syndrome	4.37e-06	6.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.37e-06	6.24e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	4.36e-06	6.23e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.35e-06	6.23e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.34e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	4.33e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.33e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.29e-06	6.14e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.29e-06	6.14e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—epilepsy syndrome	4.28e-06	6.12e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.28e-06	6.12e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.27e-06	6.11e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	4.26e-06	6.1e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.24e-06	6.07e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NGF—epilepsy syndrome	4.22e-06	6.04e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	4.21e-06	6.02e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.19e-06	5.99e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.19e-06	5.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	4.13e-06	5.91e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.12e-06	5.89e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR5—epilepsy syndrome	4.11e-06	5.88e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	4.1e-06	5.87e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	5.84e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.07e-06	5.81e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.06e-06	5.81e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	4.05e-06	5.79e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	4.05e-06	5.79e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.04e-06	5.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	4.03e-06	5.77e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—epilepsy syndrome	4.02e-06	5.75e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.02e-06	5.74e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	4.02e-06	5.74e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	3.99e-06	5.71e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	3.97e-06	5.67e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	3.96e-06	5.67e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	3.95e-06	5.65e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	3.93e-06	5.62e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.9e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	3.88e-06	5.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.88e-06	5.55e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.87e-06	5.53e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TSC2—epilepsy syndrome	3.82e-06	5.46e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGT—epilepsy syndrome	3.82e-06	5.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	3.82e-06	5.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	3.78e-06	5.4e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	3.77e-06	5.39e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—epilepsy syndrome	3.74e-06	5.35e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	3.74e-06	5.35e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	3.73e-06	5.34e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	3.72e-06	5.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.7e-06	5.29e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.69e-06	5.27e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.69e-06	5.27e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—POMC—epilepsy syndrome	3.68e-06	5.26e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.66e-06	5.24e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KDR—epilepsy syndrome	3.66e-06	5.24e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.65e-06	5.22e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	3.65e-06	5.22e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.64e-06	5.21e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.57e-06	5.11e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PRKCB—epilepsy syndrome	3.53e-06	5.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.52e-06	5.04e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6ST—epilepsy syndrome	3.51e-06	5.02e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.49e-06	5e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.49e-06	4.99e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.47e-06	4.97e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	3.45e-06	4.93e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	3.41e-06	4.87e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.38e-06	4.83e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	3.35e-06	4.8e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—epilepsy syndrome	3.35e-06	4.8e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	3.34e-06	4.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	3.34e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.33e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	3.33e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	4.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.28e-06	4.7e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.28e-06	4.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.27e-06	4.68e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.27e-06	4.67e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TH—epilepsy syndrome	3.27e-06	4.67e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.24e-06	4.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.23e-06	4.62e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.23e-06	4.61e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.22e-06	4.61e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—POMC—epilepsy syndrome	3.21e-06	4.59e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	3.19e-06	4.56e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.16e-06	4.51e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	3.14e-06	4.49e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.12e-06	4.46e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.12e-06	4.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	3.1e-06	4.44e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.08e-06	4.41e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.04e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	3.04e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	3.01e-06	4.31e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3e-06	4.29e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.97e-06	4.25e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—epilepsy syndrome	2.93e-06	4.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.93e-06	4.19e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.88e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.88e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	2.84e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.82e-06	4.04e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.82e-06	4.04e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	2.82e-06	4.03e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	2.8e-06	4e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.79e-06	3.98e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.78e-06	3.98e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.77e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.76e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	2.74e-06	3.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.73e-06	3.9e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.73e-06	3.9e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.71e-06	3.87e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAT—epilepsy syndrome	2.69e-06	3.85e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.67e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.66e-06	3.81e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.65e-06	3.79e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	2.64e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.6e-06	3.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.59e-06	3.71e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	2.59e-06	3.7e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.57e-06	3.68e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.56e-06	3.66e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.54e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	2.52e-06	3.61e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	2.45e-06	3.5e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.43e-06	3.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.42e-06	3.47e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.4e-06	3.43e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	2.38e-06	3.41e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	2.38e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.37e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.37e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.34e-06	3.35e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.32e-06	3.32e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.31e-06	3.3e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	2.31e-06	3.3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.29e-06	3.28e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-06	3.21e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	2.2e-06	3.14e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	2.18e-06	3.12e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.14e-06	3.07e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.14e-06	3.06e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.13e-06	3.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.1e-06	3e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.09e-06	2.99e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	2.07e-06	2.96e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.07e-06	2.96e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-06	2.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.99e-06	2.85e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.95e-06	2.79e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.95e-06	2.79e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.92e-06	2.75e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.91e-06	2.73e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.89e-06	2.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.81e-06	2.59e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.8e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—POMC—epilepsy syndrome	1.79e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.77e-06	2.54e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.76e-06	2.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.75e-06	2.5e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.74e-06	2.49e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.73e-06	2.48e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.71e-06	2.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.7e-06	2.43e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.68e-06	2.41e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.66e-06	2.37e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.65e-06	2.35e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.64e-06	2.34e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.64e-06	2.34e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.61e-06	2.3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.59e-06	2.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.56e-06	2.24e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.53e-06	2.19e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.52e-06	2.18e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.51e-06	2.16e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.49e-06	2.13e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—epilepsy syndrome	1.47e-06	2.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.47e-06	2.1e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	2.05e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.37e-06	1.95e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-06	1.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	9.72e-07	1.39e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	9.51e-07	1.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	9.39e-07	1.34e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.2e-07	1.03e-05	CbGpPWpGaD
